MECLIZINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Meclizine Hydrochloride patents expire, and what generic alternatives are available?
Meclizine Hydrochloride is a drug marketed by Invagen Pharms, Ivax Sub Teva Pharms, Nexgen Pharma Inc, Pliva, Abc Holding, Amneal Pharms, Anabolic, Ani Pharms, Apnar Pharma Lp, Aurobindo Pharma Usa, Bundy, Chartwell Rx, Epic Pharma Llc, Invatech, Jubilant Cadista, Kv Pharm, Rising, Sandoz, Strides Pharma, Superpharm, UDL, Vangard, Watson Labs, and Zydus Lifesciences. and is included in thirty-seven NDAs.
The generic ingredient in MECLIZINE HYDROCHLORIDE is meclizine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the meclizine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meclizine Hydrochloride
A generic version of MECLIZINE HYDROCHLORIDE was approved as meclizine hydrochloride by INVATECH on May 22nd, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MECLIZINE HYDROCHLORIDE?
- What are the global sales for MECLIZINE HYDROCHLORIDE?
- What is Average Wholesale Price for MECLIZINE HYDROCHLORIDE?
Summary for MECLIZINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 24 |
| NDAs: | 37 |
| Finished Product Suppliers / Packagers: | 28 |
| Raw Ingredient (Bulk) Api Vendors: | 182 |
| Clinical Trials: | 10 |
| Patent Applications: | 5,161 |
| What excipients (inactive ingredients) are in MECLIZINE HYDROCHLORIDE? | MECLIZINE HYDROCHLORIDE excipients list |
| DailyMed Link: | MECLIZINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MECLIZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mansoura University | Phase 1/Phase 2 |
| Hospital Federal de Bonsucesso | Phase 4 |
| Tannaz Armaghany | Phase 1 |
Pharmacology for MECLIZINE HYDROCHLORIDE
| Drug Class | Antiemetic |
| Physiological Effect | Emesis Suppression |
Medical Subject Heading (MeSH) Categories for MECLIZINE HYDROCHLORIDE
US Patents and Regulatory Information for MECLIZINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 040179-001 | Jan 30, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Invagen Pharms | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 200432-002 | Feb 17, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Vangard | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 087877-001 | Apr 20, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
